Position in SNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$37,413,673
-$25,110,187 QoQ
Shares Held
877,020
-32.4% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#38
of 712 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VAN ECK ASSOCIATES CORP holds $2,307,026,460 across 15 Drug Manufacturers - General names. SNY ranks #13 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
10,217,590 | $588,737,534 | |
| 2 | LLY |
ELI LILLY & Co
|
344,960 | $413,755,406 | |
| 3 | PFE |
Pfizer Inc
|
16,584,797 | $399,361,911 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,370,439 | $176,101,411 | |
| 5 | JNJ |
Johnson & Johnson
|
644,520 | $163,688,742 | |
| 6 | AZN |
Astrazeneca PLC
|
558,835 | $105,966,291 | |
| 7 | NVS |
Novartis AG
|
633,523 | $99,285,724 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
716,459 | $90,517,428 |
All Filings in SNY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $37,413,673 | 877,020 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $62,523,860 | 1,297,714 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $60,332,554 | 1,244,997 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $28,972,162 | 613,817 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $31,425,606 | 650,499 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $36,719,566 | 662,091 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $31,965,011 | 662,762 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $32,332,504 | 561,036 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $27,269,647 | 562,029 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $25,226,704 | 519,068 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $19,960,329 | 401,374 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $21,939,135 | 409,007 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $19,947,365 | 370,081 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $18,383,239 | 337,803 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $26,492,711 | 547,031 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $23,283,257 | 612,395 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $28,363,557 | 566,931 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $17,833,000 | 347,351 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $18,487,300 | 369,008 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $15,985,809 | 331,587 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $11,788,678 | 223,864 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $11,950,772 | 241,625 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $12,335,105 | 253,861 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $11,479,146 | 228,805 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $11,684,579 | 228,885 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $8,171,093 | 186,896 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||